Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pulse Biosciences CS
(NQ:
PLSE
)
7.360
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
7.360
Bid (Size)
7.250 (2)
Ask (Size)
8.000 (5)
Prev. Close
7.360
Today's Range
7.360 - 7.360
52wk Range
3.780 - 13.62
Shares Outstanding
54,902,942
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 01, 2024
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.
Via
Benzinga
Oxford Industries, PVH And 3 Stocks To Watch Heading Into Monday
April 01, 2024
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Performance
YTD
-33.21%
-33.21%
1 Month
-21.03%
-21.03%
3 Month
-13.31%
-13.31%
6 Month
+85.39%
+85.39%
1 Year
+27.56%
+27.56%
More News
Read More
12 Health Care Stocks Moving In Friday's After-Market Session
March 29, 2024
Via
Benzinga
PLSE Stock Earnings: Pulse Biosciences Reported Results for Q4 2023
March 28, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
March 28, 2024
Via
Benzinga
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
March 28, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Plans to Initiate a Rights Offering
March 28, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024
March 14, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Earnings Scheduled For March 28, 2024
March 28, 2024
Via
Benzinga
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
March 08, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 11, 2024
Via
Benzinga
Exposures
Product Safety
Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
February 14, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium
January 31, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
January 02, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
January 02, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
December 20, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday?
December 19, 2023
Via
Benzinga
$10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
December 13, 2023
Via
Benzinga
Insiders Buying Dave And 2 Other Stocks
December 07, 2023
Via
Benzinga
Insiders Buying Westrock Coffee And 3 Other Stocks
December 04, 2023
Via
Benzinga
Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On Tuesday
November 21, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
November 21, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference
November 15, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
November 13, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Earnings Scheduled For November 13, 2023
November 13, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.